Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3D™ bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization.
| Website | http://www.carcinotech.com |
| Employees | 11 (6 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology Research |
Looking for a particular Carcinotech employee's phone or email?
6 people are employed at Carcinotech.